American Journal of Kidney Diseases
Volume 51, Issue 5 , Pages 796-803 , May 2008

The Effect of Increasing Dialysis Dose in Overweight Hemodialysis Patients on Quality of Life: A 6-Week Randomized Crossover Trial

  • Wenjie Wang, MD, PhD, FRCPC

      Affiliations

    • Department of Medicine, Division of Nephrology, University of Calgary, Foothills Medical Center, Calgary, Alberta, Canada
    • ,
  • Marcello Tonelli, MD, MSc, FRCPC

      Affiliations

    • Institute of Health Economics, University of Alberta, Edmonton, Alberta, Canada
    • Department of Medicine, Division of Nephrology, University of Alberta, Edmonton, Alberta, Canada
    • ,
  • Brenda Hemmelgarn, MD, PhD, FRCPC

      Affiliations

    • Department of Medicine, Division of Nephrology, University of Calgary, Foothills Medical Center, Calgary, Alberta, Canada
    • Department of Community Health Sciences, University of Calgary, Foothills Medical Center, Calgary, Alberta, Canada.
    • ,
  • Song Gao, MSc

      Affiliations

    • Department of Medicine, Division of Nephrology, University of Calgary, Foothills Medical Center, Calgary, Alberta, Canada
    • ,
  • Jeffrey A. Johnson, PhD

      Affiliations

    • Institute of Health Economics, University of Alberta, Edmonton, Alberta, Canada
    • ,
  • Ken Taub, MD, MBA, FRCPC

      Affiliations

    • Department of Medicine, Division of Nephrology, University of Calgary, Foothills Medical Center, Calgary, Alberta, Canada
    • ,
  • Braden Manns, MD, MSc, FRCPC

      Affiliations

    • Department of Medicine, Division of Nephrology, University of Calgary, Foothills Medical Center, Calgary, Alberta, Canada
    • Institute of Health Economics, University of Alberta, Edmonton, Alberta, Canada
    • Department of Community Health Sciences, University of Calgary, Foothills Medical Center, Calgary, Alberta, Canada.
    • Corresponding Author InformationAddress correspondence to Braden J. Manns, MD, MSc, FRCPC, Foothills Medical Center, 1403-29th St NW, Calgary, Alberta, Canada T2N 2T9.
    • ,
  • Alberta Kidney Disease Network

Received 25 July 2007 ,Accepted 11 December 2007.

References 

  1. Kramer HJ, Saranathan A, Luke A, et al. Increasing body mass index and obesity in the incident ESRD population. J Am Soc Nephrol. 2006;17:1453–1459
  2. National Kidney Foundation. KDOQI Clinical Practice Guidelines for Hemodialysis Adequacy: Update 2006. Am J Kidney Disease. 2006;48(suppl 1):S3–S29
  3. Elangovan L, Shinaberger CS, Kraut JA, et al. HEMO equilibrated Kt/V goals are difficult to achieve in large male patients. ASAIO J. 2001;47:235–239
  4. Ifudu O, Mayers JD, Matthew JJ, et al. Standardized hemodialysis prescriptions promote inadequate treatment in patients with large body mass. Ann Intern Med. 1998;128:451–454
  5. Manns BJ, Johnson JA, Taub K, et al. Dialysis adequacy and health related quality of life in hemodialysis patients. ASAIO J. 2002;48:565–569
  6. Wolfe RA, Ashby VB, Daugirdas JT, et al. Body size, dose of hemodialysis, and mortality. Am J Kidney Dis. 2000;35:80–88
  7. Owen WF, Lew NL, Liu Y, et al. The urea reduction ratio and serum albumin concentration as predictors of mortality in patients undergoing hemodialysis. N Engl J Med. 1993;329:1001–1106
  8. Bloembergen WE, Stannard DC, Port FK, et al. Relationship of dose of hemodialysis and cause-specific mortality. Kidney Int. 1996;50:557–565
  9. Held PJ, Port FK, Wolfe RA, et al. The dose of hemodialysis and patient mortality. Kidney Int. 1996;50:550–556
  10. Salahudeen AK. Obesity and survival on dialysis. Am J Kidney Dis. 2003;41:925–932
  11. Salahudeen AK, Fleischmann EH, Bower JD. Impact of lower delivered Kt/V on the survival of overweight patients on hemodialysis. Kidney Int. 1999;56:2254–2259
  12. Eknoyan G, Beck GJ, Cheung AK, et al. Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med. 2002;347:2010–2019
  13. Unruh M, Benz R, Greene T, et al. Effects of hemodialysis dose and membrane flux on health-related quality of life in the HEMO Study. Kidney Int. 2004;66:355–366
  14. Powers KM, Wilkowski MJ, Helmandollar AW, et al. Improved urea reduction ratio and Kt/V in large hemodialysis patients using two dialyzers in parallel. Am J Kidney Dis. 2003;35:266–274
  15. Hauk M, Kuhlmann MK, Riegel W, et al. In vivo effects of dialysate flow rate on Kt/V in maintenance hemodialysis patients. Am J Kidney Dis. 2000;35:105–111
  16. Ouseph R, Ward RA. Increasing dialysate flow rate increases dialyzer urea mass transfer-area coefficients during clinical use. Am J Kidney Dis. 2001;37:316–320
  17. Fritz BA, Doss S, McCann LM, Wrone EM. A comparison of dual dialyzers in parallel and series to improve urea clearance in large hemodialysis patients. Am J Kidney Dis. 2003;41:1008–1015
  18. Sridhar NR, Hurst C, Hayes P. Tandem dialyzers with two monitors to meet target Kt/V. ASAIO J. 2005;51:65–69
  19. Manns BJ, Taub KJ. The economics of end-stage renal disease care in Canada: Incentives and impact on delivery of care. Int J Health Care Finance Econ. 2007;7:149–169
  20. Canadian Coordinating Office for Health Technology Assessment. Guidelines for Economic Evaluation of Pharmaceuticals: Canada. Ottawa, Canada: The Canadian Coordinating Office for Health Technology Assessment; 2006;
  21. Hays RD, Kallich JD, Mapes DL, et al. Kidney Disease Quality of Life Short Form, version 1.3: A Manual for Use and Scoring (Report). Santa Monica, CA: RAND; 1995;
  22. Hays RD, Kallich JD, Mapes DL, et al. Development of the Kidney Disease Quality of Life (KDQOL) instrument. Qual Life Res. 1994;3:329–338
  23. Korevaar JC, Jansen MA, Merkus MP, et al. Quality of life in predialysis end-stage renal disease patients at the initiation of dialysis therapy (The NECOSAD Study Group). Perit Dial Int. 2000;20:69–75
  24. Hays RD, Sherbourne C, Mazel R, et al. User's Manual for Medical Outcomes Study (MOS) Core Measures of Health-Related Quality of Life. Santa Monica, CA: RAND; 1995;
  25. McHorney CA, Ware JE, Lu JF, et al. The MOS 36-Item Short-Form Health Survey (SF-36): III (Tests of data quality, scaling assumptions, and reliability across diverse patient groups). Med Care. 1994;32:40–66
  26. Furlong WJ, Feeny DH, Torrance GW, et al. The Health Utilities Index (HUI) system for assessing health-related quality of life in clinical studies. Ann Med. 2001;33:375–384
  27. Norman GSJ, Wyrwich KTW. Interpretation of changes in health-related quality of life: The remarkable universality of half a standard deviation. Med Care. 2003;41:582–592
  28. Wyrwich KTW, Babu AN, Kroenke K, et al. A comparison of clinically important differences in health-related quality of life for patients with chronic lung disease, asthma, or heart disease. Health Serv Res. 2005;40:577–591
  29. McCallagh P, Nelder JA. Generalized Linear Models. (ed 2). London, UK: Chapman & Hall; 1989;
  30. Nelder JA, Wedderburn RWM. Generalized linear models. J R Stat Soc. 1972;135:370–384

 Originally published online as doi:10.1053/j.ajkd.2007.12.031 on March 28, 2008.

PII: S0272-6386(08)00063-2

doi: 10.1053/j.ajkd.2007.12.031

American Journal of Kidney Diseases
Volume 51, Issue 5 , Pages 796-803 , May 2008

Article Tools

* Image Usage & Resolution